Accuracy and Precision of Radioactivity Quantification in Nuclear Medicine Images

Written by Eric C. Frey, John L. Humm, Michael Ljungberg on May 1, 2012 – 11:00 pm -

The ability to reliably quantify activity in nuclear medicine has a number of increasingly important applications. Dosimetry for targeted therapy treatment planning or for approval of new imaging agents requires accurate estimation of the activity in organs, tumors, or voxels at several imaging time points. Another important application is the use of quantitative metrics derived from images, such as the standard uptake value commonly used in positron emission tomography (PET), to diagnose and follow treatment of tumors. These measures require quantification of organ or tumor activities in nuclear medicine images. However, there are a number of physical, patient, and technical factors that limit the quantitative reliability of nuclear medicine images. There have been a large number of improvements in instrumentation, including the development of hybrid single-photon emission computed tomography/computed tomography and PET/computed tomography systems, and reconstruction methods, including the use of statistical iterative reconstruction methods, which have substantially improved the ability to obtain reliable quantitative information from planar, single-photon emission computed tomography, and PET images.

Posted in Nuclear medicine | Comments Off

Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms

May 1, 2012 – 11:00 pm

Theranostics of neuroendocrine neoplasms (NENs) based on molecular imaging using ...

Comments Off

FDG for Therapy of Metabolically Active Tumors

May 1, 2012 – 11:00 pm

18F-2-deoxy-2-fluoro-d-glucose (18F-FDG, later referred to as 19FDG) has been extensively ...

Comments Off

Theranostics: Evolution of the Radiopharmaceutical Meta-Iodobenzylguanidine in Endocrine Tumors

May 1, 2012 – 11:00 pm

Since 1981, meta-iodobenzylguanidine (MIBG), labeled with 131I and later 123I, ...

Comments Off

Radioiodine: The Classic Theranostic Agent

May 1, 2012 – 11:00 pm

Radioiodine has the distinction of being the first theranostic agent ...

Comments Off

Paving the Way to Personalized Medicine: Production of Some Promising Theragnostic Radionuclides at Brookhaven National Laboratory

May 1, 2012 – 11:00 pm

This article reintroduces and reinforces our proposed paradigm that involves ...

Comments Off

Concepts, Consequences, and Implications of Theranosis

May 1, 2012 – 11:00 pm

Although the term has been coined recently, the concepts underlying ...

Comments Off

Letter from the Editors: Theranostics

May 1, 2012 – 11:00 pm

We have decided to devote this issue of Seminars to ...

Comments Off

Update on Gastrointestinal Radiopharmaceuticals and Dosimetry Estimates

March 1, 2012 – 11:00 pm

The gold standard technique for measuring gastric emptying is scintigraphy ...

Comments Off

Liver Function Testing with Nuclear Medicine Techniques Is Coming of Age

March 1, 2012 – 11:00 pm

Liver function is a broad term, as the organ participates ...

Comments Off
RSS